| |
Home »
News » 02/06
» Sanofi-Aventis recalls Clexane syringes
Sanofi-Aventis recalls Clexane syringes
Date published: 16/02/2006
Sanofi-Aventis has recalled 30 batches
of the anticoagulant Clexane (enoxaparin). The move was made after quality
control tests found there was the possibility that there could be an
over-concentration of the active ingredient in a limited number of
syringes.
The syringes were delivered to Europe, Latin America, Asia and
Africa and the UK is on the list of countries which could be affected. The
company stated: "It is important to note that the enoxaparin active ingredient
is not the subject of this recall." The problem stemmed from a change to the
syringe filling process that was put into place in April 2005. Sanofi-Aventis
is to be in contact with all the relevant health authorities and patients,
healthcare professionals, pharmacists and wholesalers are to be informed.
© Adfero Ltd
Disclaimer
AllAboutMedicalSales excludes any warranty, express or implied, as to
the quality, accuracy, timeliness, completeness or fitness for a particular
purpose of this briefing. AllAboutMedicalSales will not be liable for any
claims, penalties, losses, damages, costs, or expenses arising from the use of
or inability to use this briefing or from any unauthorised access to or
alteration of the Briefing. AllAboutMedicalSales makes no warranty that the
contents of this briefing are compatible with all computer systems and
browsers.
|
